DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
VSFRX
Price
$28.70
Change
-$0.10 (-0.35%)
Updated
Jul 31 closing price
Net Assets
170.4M
Interact to see
Advertisement

DFSVX vs VSFRX

DFSVX vs VSFRX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. VSFRX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and VSFRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. VSFRX (170M). DFSVX pays higher dividends than VSFRX: DFSVX (1.50) vs VSFRX (0.86). DFSVX was incepted earlier than VSFRX: DFSVX (33 years) vs VSFRX (16 years). VSFRX (1.77) is less costly to investors than DFSVX (0.31). VSFRX is a more actively managed with annual turnover of: 59.00 vs. DFSVX (7.00). DFSVX (0) and VSFRX (0) have matching initial minimum investment requirements. DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. VSFRX (24.65). DFSVX return over 5 years is better than : 50.66 vs. VSFRX (10.97).
DFSVXVSFRXDFSVX / VSFRX
Total Expense Ratio0.311.2325%
Annual Report Gross Expense Ratio0.311.7718%
Fund Existence33 years16 years-
Gain YTD21.33618.302117%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B170M11,471%
Annual Yield % from dividends1.500.86174%
Returns for 1 year34.3924.65140%
Returns for 3 years50.3723.89211%
Returns for 5 years50.6610.97462%
Returns for 10 years107.7126.80402%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I